Patent Assignment
Reel/Frame 047160/0234
Entity Conversion
Recorded: 2018-09-28
Pages: 67
Assignor
NABRIVA THERAPEUTICS AG
Executed: 2017-10-19
Assignee
NABRIVA THERAPEUTICS GMBH
LEBERSTRASSE 20, VIENNA, 1110, AUSTRIA
Covered Property
(1)
Pleuromutilin Derivatives Having Antibacterial Activity
Related Assignments
(8)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 10, 2004
From: ASCHER, GERD; BERNER, HEINZ
To: SANDOZ GMBH (FORMERLY BIOCHEMIE GMBH)
Reel/Frame 015311/0040 →
Assignment of Assignor's Interest
Aug 13, 2008
From: SANDOZ GMBH
To: NABRIVA THERAPEUTICS AG
Reel/Frame 021380/0209 →
Security Interest
Aug 28, 2014
From: NABRIVA THERAPEUTICS AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 033647/0657 →
Release of Security Interest
Jan 11, 2016
From: KREOS CAPITAL IV (UK) LIMITED
To: NABRIVA THERAPEUTICS AG
Reel/Frame 037455/0436 →
Intellectual Property Security Agreement
Dec 20, 2018
From: NABRIVA THERAPEUTICS GMBH
To: HERCULES CAPITAL, INC.
Reel/Frame 047973/0110 →
Security Interest
Jan 18, 2019
From: NABRIVA THERAPEUTICS GMBH
To: HERCULES CAPITAL, INC.
Reel/Frame 048062/0807 →
Release of Security Interest
Mar 3, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH; ZAVANTE THERAPEUTICS, INC.
Reel/Frame 062881/0090 →
Corrective Assignment to Correct the Receiving Party Data and the Assignment Document Previously Recorded at Reel: 062881 Frame: 0090. Assignor(S) Hereby Confirms the Release of Security Interest.
Jun 20, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 064312/0350 →